Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer

British Journal of Cancer
T KamaiK I Yoshida

Abstract

The p27(Kip1)(p27) protein is a cyclin-dependent kinase inhibitor of the transition from G1 to S phase. It has been reported that decreased p27 protein level is a negative prognostic indicator in human tumours including bladder cancer. We studied the relationship between protein levels of p27, cyclin E and Ki-67 and clinicopathological features of 145 consecutive Japanese patients with transitional cell carcinoma of the bladder using immunohistochemical staining. Low protein levels of p27 were associated with low staining of cyclin E (P = 0.0302), high Ki-67 index (P = 0.0306), poorly differentiated grade (P = 0.0006), muscle invasion (P = 0.0019) and lymph node metastsis (P = 0.0002). Low staining of cyclin E and high Ki-67 index correlated with poorly differentiated grade, muscle invasion and lymph node metastsis. Cyclin E protein levels was inversely related with Ki-67 index (P = 0.0002). Kaplan-Meier plots of survival rate in patients with low versus high p27 staining showed that low protein levels of p27 were associated with a shortened disease-free and overall survival (P< 0.0001 and P< 0.0001, respectively). Similarly, low staining of cyclin E and high Ki-67 index correlated with a shortened disease-free and overall surv...Continue Reading

Citations

Feb 4, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Adam S FeldmanBruce R Zetter
Dec 17, 2014·International Journal of Molecular Sciences·Xunlei ZhangCuiju Tang
Dec 22, 2012·Expert Opinion on Investigational Drugs·Seok Joong YunWun-Jae Kim
Mar 30, 2005·BJU International·Maurizio BuscariniJohn P Stein
Mar 8, 2008·BJU International·Vitaly MargulisShahrokh F Shariat
Apr 2, 2008·Cancer Science·Wun-Jae Kim, Suk-Chul Bae
Jul 19, 2014·Critical Reviews in Clinical Laboratory Sciences·Francesca SanguedolceLuigi Cormio
Oct 9, 2008·Annual Review of Pathology·Anirban P Mitra, Richard J Cote
Nov 5, 2003·The Journal of Pathology·A BarnesI O Ellis
Dec 21, 2011·Journal of Applied Toxicology : JAT·Kumiko OgawaTomoyuki Shirai
Jan 16, 2007·The Journal of Urology·Shahrokh F ShariatYair Lotan
Oct 26, 2006·World Journal of Urology·Christopher Y Thomas, Dan Theodorescu
Aug 22, 2007·World Journal of Urology·Anirban P MitraRichard J Cote
Sep 1, 2008·Proteomics. Clinical Applications·Sulma I Mohammed, Munazzah Rahman
Jun 29, 2010·Histopathology·Ian ProctorGareth H Williams
Dec 8, 2007·Expert Review of Anticancer Therapy·Marc BirkhahnRichard J Cote
Mar 13, 2008·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·Andrea BrunnerAlexandar Tzankov
Apr 13, 2012·Cancer Science·Minoru KatoHideki Wanibuchi
Apr 2, 2016·Medical Oncology·Soni KumariGopeshwar Narayan
Jul 14, 2020·Cell Transplantation·Jianfeng XuJianguo Xu
Nov 27, 2007·International Journal of Urology : Official Journal of the Japanese Urological Association·Ting-Ying FuJyh-Seng Wang
Aug 16, 2016·Molecular Cancer Research : MCR·Jillian M PattisonMichael D Cole
Mar 5, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kamal E Bani-HaniHanan N Karam
Aug 9, 2011·Anti-cancer Drugs·Stefan ValloRoman A Blaheta
Aug 6, 2003·Critical Reviews in Oncology/hematology·Sana Al-Sukhun, Maha Hussain
Dec 9, 2008·Archives of Pathology & Laboratory Medicine·Foteini KarasavvidouGeorge Koukoulis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.